http://rdf.ncbi.nlm.nih.gov/pubchem/patent/GB-1405135-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d1ba908e0573bb431013682a505a0a12 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D498-08 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D498-08 |
| filingDate | 1972-08-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 1975-09-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | GB-1405135-A |
| titleOfInvention | Antileukaemic ansa macrolides |
| abstract | 1405135 Anti-tumour medicaments S M KUPCHAN 23 Aug 1972 39181/72 Heading A5B [Also in Division C2] Pharmaceutical compositions, suitable for parenteral administration, contain macrolides of the formula: where R is CH 3 (Maytansine), CH 2 CH 3 (Maytanprine) or CH(CH 3 ) 2 (Maytabutine) or 9-O- (3-bromopropyl) maytansine and pharmaceutically acceptable carriers and, if desired, other active ingredients such as mechlorethamine hydrochloride, S-[bis (2-chloroethyl) amino] uracil, triethylenemelamine, actinomycin C or cyloheximide. The compounds possess activity tumor inhibitory activity. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4190580-A |
| priorityDate | 1972-08-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 27.